ES2056967T3 - Ws-9326a, ws-9326b y sus derivados. - Google Patents

Ws-9326a, ws-9326b y sus derivados.

Info

Publication number
ES2056967T3
ES2056967T3 ES89101607T ES89101607T ES2056967T3 ES 2056967 T3 ES2056967 T3 ES 2056967T3 ES 89101607 T ES89101607 T ES 89101607T ES 89101607 T ES89101607 T ES 89101607T ES 2056967 T3 ES2056967 T3 ES 2056967T3
Authority
ES
Spain
Prior art keywords
refers
salts
derivatives
streptomices
ferm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89101607T
Other languages
English (en)
Inventor
Tohru Kino
Motoaki Nishikawa
Masami Ezaki
Sumio Kiyoto
Masakuni Okuhara
Shigehiro Takase
Satoshi Okada
Nobuharu Shigematsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2056967T3 publication Critical patent/ES2056967T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

ESTA APLICACION SE REFIERE A LOS NUEVOS COMPUESTOS LLAMADOS WS 932B, Y SUS DERIVADOS, QUE POSEEN VALIOSAS PROPIEDADES FARMACEUTICAS Y QUE SE OBTIENEN CULTIVANDO UN WS - 9326A Y/O WS - 9326B QUE PRODUCEN PERTENECIENTE AL GENERO STREPTOMICES EN EL MEDIO NUTRIENTE Y QUE RECUBREN DICHOS COMPUESTOS O SALES DE LOS MISMOS A PARTIR DEL DE CULTIVO RESULTANTE. LA INVENCION TAMBIEN SE REFIERE A UN PROCESO PARA SU PRODUCCION Y A COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN O SALES DE LAS MISMAS ACEPTABLES FARMACEUTICAMENTE, COMO INGREDIENTE ACTIVO. LA INVENCION SE REFIERE TAMBIEN A UN CULTIVO BIOLOGICAMENTE PURO DEL MICROORGANISMO STREPTOMYCES VIOLACEONIGER NO 9326 (FERM BP - 1667).
ES89101607T 1988-02-02 1989-01-31 Ws-9326a, ws-9326b y sus derivados. Expired - Lifetime ES2056967T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888802229A GB8802229D0 (en) 1988-02-02 1988-02-02 Ws-9326 & its derivatives

Publications (1)

Publication Number Publication Date
ES2056967T3 true ES2056967T3 (es) 1994-10-16

Family

ID=10630888

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89101607T Expired - Lifetime ES2056967T3 (es) 1988-02-02 1989-01-31 Ws-9326a, ws-9326b y sus derivados.

Country Status (9)

Country Link
EP (1) EP0327009B1 (es)
JP (1) JPH0676425B2 (es)
KR (1) KR970009151B1 (es)
AT (1) ATE108480T1 (es)
CA (1) CA1338261C (es)
DE (1) DE68916659T2 (es)
ES (1) ES2056967T3 (es)
GB (1) GB8802229D0 (es)
IE (1) IE64227B1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8807921D0 (en) * 1988-04-05 1988-05-05 Fujisawa Pharmaceutical Co Ws-9326 & its derivatives
IE64214B1 (en) * 1989-06-06 1995-07-26 Fujisawa Pharmaceutical Co Macrolides for the treatment of reversible obstructive airways diseases
US5830854A (en) * 1992-12-14 1998-11-03 Merck Sharp & Dohme, Limited Method of treating cystic fibrosis using a tachykinin receptor antagonist
US8093268B2 (en) 2007-01-24 2012-01-10 Glaxo Group Limited Pharmaceutical compositions comprising 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-(2S-phenylpiperidin-3S-yl-)
UA105182C2 (ru) 2008-07-03 2014-04-25 Ньюрексон, Інк. Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность
US9446029B2 (en) 2010-07-27 2016-09-20 Colorado State University Research Foundation Use of NK-1 receptor antagonists in management of visceral pain

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1302926C (en) * 1986-03-04 1992-06-09 Hideo Sugawara Antibiotic f-0769, process for its production, and its use as a growthaccelerating and feed efficiency increasing agent and as an antitumour agent

Also Published As

Publication number Publication date
KR970009151B1 (ko) 1997-06-07
IE890208L (en) 1989-08-02
ATE108480T1 (de) 1994-07-15
CA1338261C (en) 1996-04-23
DE68916659T2 (de) 1994-11-17
JPH01304888A (ja) 1989-12-08
KR890013191A (ko) 1989-09-21
JPH0676425B2 (ja) 1994-09-28
EP0327009B1 (en) 1994-07-13
EP0327009A1 (en) 1989-08-09
DE68916659D1 (de) 1994-08-18
IE64227B1 (en) 1995-07-26
GB8802229D0 (en) 1988-03-02

Similar Documents

Publication Publication Date Title
AU4921590A (en) Pf 1022 substance, method of producing same and anthelmintic composition containing same
KR890002214A (ko) 데만노실 테이코플라닌 유도체
ES8501440A1 (es) Procedimiento para la preparacion de nuevas sustancias ws 6049.
IE890208L (en) Ws-9326a, ws-9326b and their derivatives
US4578383A (en) CL 1565 antibiotic compounds
KR890005139A (ko) 테이코플라닌 유사 유도체
US5756536A (en) Microbial transformation of taxol and cephalomannine
HUT46945A (en) Process for producing new azoxy derivatives and pharmaceutical compositions containing them as active components
NO901160L (no) Fremgangsmaate for fremstilling av ws 7622a, b, c og d stoffer og derivater derav.
ES2080068T3 (es) Derivados de 2-piranona y su procedimiento de preparacion.
ATE62248T1 (de) Ein doxorubicinderivat, ein verfahren zu dessen herstellung, pharmazeutische zusammensetzungen und dessen verwendung fuer die herstellung von arzneimitteln.
KR900004939A (ko) 농화학적으로 유용한 활성 성분들의 미생물에 의한 제조 방법
KR920002795A (ko) 항생제 발히마이신, 이의 제조방법 및 약제로서 이의 용도
ES467562A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1-azabiciclo (3.2.0) hept-2-en-2-carboxilico
ES8801703A1 (es) Un nuevo procedimiento para producir el (los) antibiotico (s) macrolido (s) 4s-02930 k-d-e o-h.
KR880008972A (ko) 카르복실산 유도체
DE69013809D1 (de) Antibiotikum.
JP3530563B2 (ja) Ｋｏ−８１１９物質及びその製造法
KR860002574A (ko) 항생물질 at 2433 복합체의 제조방법
JPS6456680A (en) Antibiotic substance 6270b
EP0333177A3 (en) Fr-900493 substance, a process for its production and a pharmaceutical composition containing the same
JPS6479118A (en) Antitumor agent
JPS63280073A (ja) 新規抗生物質ｙｐ−０２９７８ｌ−ｃ及びその製造方法
JPH0892272A (ja) 癌悪液質治療物質ｆｒ１７７３９１

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 327009

Country of ref document: ES